ストックスクリーナーアプリを入手
20.14
37.04%
-11.85
前日終値:
$31.99
開ける：
$22.75
24時間の取引高:
8.13M
Relative Volume:
9.63
時価総額：
$886.66M
収益：
$78.02M
当期純損益:
$-73.37M
株価収益率:
-15.26
EPS:
-1.32
ネットキャッシュフロー:
$-62.06M
1週間 パフォーマンス:
-31.15%
1か月 パフォーマンス:
-30.58%
6か月 パフォーマンス:
+51.66%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$20.02
$23.92
1週間の範囲:
$20.02
$32.58
52週間の値動き範囲:
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
BBNX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
20.14 | 1.41B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-10-01 | アップグレード | Goldman | Neutral → Buy |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-06-12 | 開始されました | Lake Street | Buy |
| 2025-05-30 | 開始されました | Goldman | Neutral |
| 2025-05-30 | 開始されました | Wolfe Research | Outperform |
| 2025-02-24 | 開始されました | BofA Securities | Buy |
| 2025-02-24 | 開始されました | Lake Street | Buy |
| 2025-02-24 | 開始されました | Leerink Partners | Outperform |
| 2025-02-24 | 開始されました | Piper Sandler | Overweight |
| 2025-02-24 | 開始されました | Stifel | Buy |
| 2025-02-20 | 開始されました | Ladenburg Thalmann | Neutral |
| 2025-02-20 | 開始されました | Robert W. Baird | Neutral |
すべてを表示
Beta Bionics Inc (BBNX) 最新ニュース
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm - The AI Journal
Beta Bionics, Inc.'s (NASDAQ:BBNX) Popularity With Investors Under Threat As Stock Sinks 31% - 富途牛牛
Does Beta Bionics (BBNX) Strong Q4 Sales Outlook Reshape Confidence in Its Long-Term Strategy? - simplywall.st
Why Beta Bionics Inc. stock is a value investor pickMarket Sentiment Summary & Long-Term Growth Stock Strategies - ulpravda.ru
Beta Bionics Stock (-37%): Patient Growth Miss Spooks Street - Trefis
Beta Bionics Shares Fall After BofA Securities Downgrade - MarketScreener
Midday Stock Roundup: loanDepot Rises on Trump Move - Orange County Business Journal
Beta Bionics Tumbles 32% on Analyst Downgrade - Orange County Business Journal
Beta Bionics stock tumbles following deceleration in new patient starts By Investing.com - Investing.com UK
Beta Bionics stock tumbles following deceleration in new patient starts - Investing.com
BofA Securities Downgrades Beta Bionics to Neutral From Buy, Adjusts Price Target to $28 From $33 - MarketScreener
Premium Valuation and Slowing New Patient Growth Drive Shift to Neutral on Beta Bionics - TipRanks
Beta Bionics stock to exceed Q4 revenue targets, Stifel maintains Buy - Investing.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Weekly Trades: Is Beta Bionics Inc. stock positioned for digital transformation2025 AllTime Highs & Accurate Buy Signal Notifications - ulpravda.ru
How Beta Bionics Inc. stock reacts to inflationary pressuresJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - ulpravda.ru
BofA Securities downgrades Beta Bionics stock to Neutral on valuation concerns - Investing.com Australia
How Beta Bionics Inc. stock performs in weak economy2025 Trade Ideas & Smart Money Movement Tracker - ulpravda.ru
Is Beta Bionics Inc. stock a safe buy before earningsGap Up & Trade Opportunity Analysis Reports - ulpravda.ru
Will Beta Bionics Inc. stock attract more institutional investorsWeekly Profit Report & Free Reliable Trade Execution Plans - ulpravda.ru
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics - GlobeNewswire
Is Beta Bionics Inc. stock positioned for digital transformation2025 AllTime Highs & Accurate Buy Signal Notifications - ulpravda.ru
Will Beta Bionics Inc. stock keep outperforming rivalsJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Insider Sell: Mike Mensinger Sells 2,200 Shares of Beta Bionics Inc (BBNX) - GuruFocus
Insider Sell: Mike Mensinger Sells 7,800 Shares of Beta Bionics Inc (BBNX) - GuruFocus
Mike Mensinger Sells 7,800 Shares of Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
Insider Selling: Beta Bionics (NASDAQ:BBNX) CFO Sells 20,000 Shares of Stock - MarketBeat
Beta Bionics CFO Sells 20,000 Shares - TradingView — Track All Markets
BBNX Receives "Buy" Rating from B of A Securities with Increased - GuruFocus
Bank of America Forecasts Strong Price Appreciation for Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
Beta Bionics, Inc. (BBNX) Investor Outlook: Strong Buy Ratings and Growth Potential in the Healthcare Sector - DirectorsTalk Interviews
FOMO Trade: How Beta Bionics Inc stock reacts to inflationary pressuresWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Aug Weekly: Why analysts upgrade Beta Bionics Inc stockLayoff News & Community Supported Trade Ideas - moha.gov.vn
Beta Bionics Reports Strong Q3 Growth Amid Challenges - MSN
Fourteen new option listings on November 12th - MSN
Beta Bionics, Inc. (BBNX) Stock Analysis: A Promising Growth Story with 63.10% Revenue Surge - DirectorsTalk Interviews
Artificial Pancreas System Market is set for steady growth to US$ - openPR.com
Beta Bionics (NASDAQ:BBNX) Trading Up 8.7%Should You Buy? - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Review: How Beta Bionics Inc. stock performs during Fed tightening cyclesJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда
Why Beta Bionics Inc. stock is a must watch in 20252025 Price Action Summary & Low Risk High Win Rate Picks - Улправда
Why Beta Bionics Inc. stock is rated strong buyMarket Growth Summary & Intraday High Probability Setup Alerts - DonanımHaber
How Beta Bionics Inc. stock performs during Fed tightening cyclesJuly 2025 Volume & Safe Capital Growth Stock Tips - Улправда
Truist Securities Maintains Beta Bionics (BBNX) Buy Recommendation - Nasdaq
Is Beta Bionics (BBNX) Overvalued After Its Recent Share Price Momentum? - Yahoo Finance
Beta Bionics (NASDAQ:BBNX) Sees Strong Trading Volume Following Analyst Upgrade - MarketBeat
Truist Securities Adjusts Price Target on Beta Bionics to $37 From $32, Maintains Buy Rating - marketscreener.com
Beta Bionics (NASDAQ:BBNX) Given New $37.00 Price Target at Truist Financial - MarketBeat
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas - MSN
Beta Bionics Earnings Notes - Trefis
Beta Bionics stock rating reiterated at Buy by Stifel - Investing.com Australia
Beta Bionics Inc (BBNX) 財務データ
収益
当期純利益
現金流量
EPS
1.31%
0.51%
大文字化:
|
ボリューム (24 時間):